FTC should scrutinize oncology deals, US Senator Warren says
MLex Summary: US Senator Elizabeth Warren urged the US Federal Trade Commission to "closely scrutinize" a pair of oncology deals. McKesson Corp.'s proposed $2.49 billion acquisition of Core Ventures and Cardinal...To view the full article, register now.
Already a subscriber? Click here to view full article